Wildcat, great post!!! Thank for your insight and diligence that you have provided for us. I most certainly agree with your statements about the future of ScripsAmerica, their RapiMeds product as well as all of the other opportunities for patent extension with other drugs and over the counter generics. I highlighted a few points from the news that had been released concerning the contract status for Global Distribution. In my opinion, this GO GLOBAL strategy is rather significant due to the advantages made available to small start-up and venture capital endeavors. I have been working on some research to add to the board sometime this week and when I am complete it I will share with the board. However, I quickly I will go over some of the benefits made available to ScripsAmerica by choosing a business model with an international reach.
PROACTIVE REASONS
1. Increased profits
2. Unique goods or services
3. Technological advantage
4. Exclusive market information
5. Owner-manager desire
6. Economies of scale
REACTIVE REASONS
1. Competitive pressures
2. Declining domestic demand
3. Overcapacity
4. Proximity to customers
5. Counterattack foreign competition
Global Strategies
A. EXPORT STRATEGIES
B. CONTRACTUAL STRATEGIES
C. INVESTMENT STRATEGIES
EXPORT STRATEGIES
A. INDIRECT
B. DIRECT AGENT / DISTRIBUTOR
C. DIRECT BRANCH / SUBSIDIARY
CONTRACTUAL STRATEGIES
* LICENSING
* FRANCHISING
* TECHNICAL AGREEMENTS
* SERVICE CONTRACTS
* MANAGEMENT CONTRACTS
* CONSTRUCTION / TURNKEY CONTRACTS
* CONTRACT MANUFACTURE
* COUNTERTRADE AGREEMENTS
INVESTMENT STRATEGIES
1. SOLE VENTURE
(a) NEW ESTABLISHMENT
(b) ACQUISITION
2. JOINT VENTURE
(a) NEW ESTABLISHMENT
(b) ACQUISITION
GLOBAL FRANCHISE EXPLOSION
* Increased disposable income
* Rising educational levels
* Universal cultural trends
* More women entering workforce
* Smaller families with more incomes
* Enthusiasm of younger generations
* Demand for quality & service
"It is important to remember that we are positioning ScripsAmerica's growth in China to be a part of the country's 'Go Global' strategy, whereby the government is providing billions of dollars in loans to foreign countries to acquire Chinese manufactured goods through banks and investing partners. It is not a stretch of the imagination to envision the manufacture and export of Scrips-China RapiMed® products into this exploding global marketplace."
The official "Memorandum of Understanding" will be submitted to ScripsAmerica on June 25th to be signed by both parties the week of July 5th. (Last Week) The Company expects the signing of the "Definitive Agreement" to occur before the end of September, which will include initial production and shipping schedules.
News 
Market Data 
Discover 
AI
